Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Goldsmith

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Cardiac Failure|May 26, 2026
Thiazides attenuate the diuretic response to Pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patientsDaan C H Ceelen, Geert H D Voordes, Lucija Cosic, et al.
Circulation. Heart Failure|June 5, 2015
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF)Anuradha Lala, Steven E McNulty, Robert J Mentz, et al.
Journal of Cardiac Failure|March 6, 2012
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research NetworkBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JACC. Heart Failure|December 30, 2014
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failureRobert J Mentz, Susanna R Stevens, Adam D DeVore, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2017
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunctionYuya Matsue, Jozine M Ter Maaten, Makoto Suzuki, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Cardiac Failure|May 26, 2026
Thiazides attenuate the diuretic response to Pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patientsDaan C H Ceelen, Geert H D Voordes, Lucija Cosic, et al.
Circulation. Heart Failure|June 5, 2015
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF)Anuradha Lala, Steven E McNulty, Robert J Mentz, et al.
Journal of Cardiac Failure|March 6, 2012
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research NetworkBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JACC. Heart Failure|December 30, 2014
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failureRobert J Mentz, Susanna R Stevens, Adam D DeVore, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2017
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunctionYuya Matsue, Jozine M Ter Maaten, Makoto Suzuki, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Pageof 6